{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T23:56:04Z","timestamp":1769644564405,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11463-0","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:28:48Z","timestamp":1769599728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LINC00265 is significantly upregulated in breast carcinoma: expression, correlation networks, and potential prognostic value"],"prefix":"10.1007","volume":"53","author":[{"given":"Zahra","family":"Tajik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farkhondeh","family":"Pouresmaeili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solat","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobat","family":"Geranpayeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ghadyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"11463_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A, Cancer statistics (2025) CA: a cancer journal for clinicians. 2025;75(1):10\u201345","DOI":"10.3322\/caac.21871"},{"key":"11463_CR2","doi-asserted-by":"publisher","first-page":"1622954","DOI":"10.3389\/fpubh.2025.1622954","volume":"13","author":"O Freihat","year":"2025","unstructured":"Freihat O, Sipos D, Kovacs A (2025) Global burden and projections of breast cancer incidence and mortality to 2050: a comprehensive analysis of GLOBOCAN data. Front Public Health 13:1622954","journal-title":"Front Public Health"},{"issue":"6","key":"11463_CR3","first-page":"524","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A et al (2022) Breast Cancer Stat 2022 CA: Cancer J Clin 72(6):524\u2013541","journal-title":"Breast Cancer Stat 2022 CA: Cancer J Clin"},{"issue":"3","key":"11463_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.seminoncol.2010.05.006","volume":"37","author":"JM Croswell","year":"2010","unstructured":"Croswell JM, Ransohoff DF, Kramer BS (2010) Principles of cancer screening: lessons from history and study design issues. Semin Oncol 37(3):202\u2013215","journal-title":"Semin Oncol"},{"issue":"2","key":"11463_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5306\/wjco.v8.i2.120","volume":"8","author":"V Masoud","year":"2017","unstructured":"Masoud V, Pag\u00e8s G (2017) Targeted therapies in breast cancer: new challenges to fight against resistance. World J Clin Oncol 8(2):120\u2013134","journal-title":"World J Clin Oncol"},{"issue":"2","key":"11463_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10549-012-2289-9","volume":"136","author":"H Masuda","year":"2012","unstructured":"Masuda H, Zhang D, Bartholomeusz C, Doihara H, Hortobagyi GN, Ueno NT (2012) Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res Treat 136(2):331\u2013345","journal-title":"Breast Cancer Res Treat"},{"key":"11463_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1126\/scitranslmed.abb2914","volume":"13","author":"K Li","year":"2021","unstructured":"Li K, Zhang TT, Zhao CX, Wang F, Cui B, Yang ZN et al (2021) Faciogenital dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability. Sci Transl Med 13:586","journal-title":"Sci Transl Med"},{"key":"11463_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2147\/CMAR.S225376","volume":"12","author":"X Song","year":"2020","unstructured":"Song X, Liu Z, Yu Z (2020) EGFR promotes the development of triple negative breast cancer through JAK\/STAT3 signaling. Cancer Manag Res 12:703\u2013717","journal-title":"Cancer Manag Res"},{"issue":"3","key":"11463_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1878-0261.12162","volume":"12","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Ma J, Fan Y, Wang Z, Tian R, Ji W et al (2018) TGF-\u03b2 transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK\/Sp1 signaling pathways. Mol Oncol 12(3):305\u2013321","journal-title":"Mol Oncol"},{"key":"11463_CR10","doi-asserted-by":"publisher","first-page":"108037","DOI":"10.1016\/j.bioorg.2024.108037","volume":"154","author":"SR Shetty","year":"2025","unstructured":"Shetty SR, Kar T, Das A (2025) Epidermal growth factor receptor mutations in breast cancer: therapeutic challenges and way forward. Bioorg Chem 154:108037","journal-title":"Bioorg Chem"},{"key":"11463_CR11","doi-asserted-by":"publisher","first-page":"114661","DOI":"10.1016\/j.ejmech.2022.114661","volume":"241","author":"MA Sabry","year":"2022","unstructured":"Sabry MA, Ghaly MA, Maarouf AR, El-Subbagh HI (2022) New thiazole-based derivatives as EGFR\/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity. Eur J Med Chem 241:114661","journal-title":"Eur J Med Chem"},{"key":"11463_CR12","doi-asserted-by":"publisher","first-page":"107849","DOI":"10.1016\/j.bioorg.2024.107849","volume":"153","author":"SR Shetty","year":"2024","unstructured":"Shetty SR, Debnath S, Majumdar K, Rajagopalan M, Ramaswamy A, Das A (2024) Virtual screening, molecular dynamics simulations, and in vitro validation of EGFR inhibitors as breast cancer therapeutics. Bioorg Chem 153:107849","journal-title":"Bioorg Chem"},{"key":"11463_CR13","doi-asserted-by":"crossref","unstructured":"Li X, Zhao L, Chen C, Nie J, Jiao B (2022) Can EGFR be a therapeutic target in breast cancer? Biochimica et biophysica acta (BBA) - Reviews on cancer. Biochim Biophys Acta Rev Cancer. 1877(5):188789","DOI":"10.1016\/j.bbcan.2022.188789"},{"key":"11463_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.18632\/oncotarget.28747","volume":"16","author":"S Shyamsunder","year":"2025","unstructured":"Shyamsunder S, Lu Z, Takiar V, Waltz SE (2025) Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: insights into RTK dependent and independent mechanisms. Oncotarget 16:508\u2013530","journal-title":"Oncotarget"},{"issue":"15","key":"11463_CR15","doi-asserted-by":"publisher","first-page":"e35208","DOI":"10.1016\/j.heliyon.2024.e35208","volume":"10","author":"H Aria","year":"2024","unstructured":"Aria H, Azizi M, Nazem S, Mansoori B, Darbeheshti F, Niazmand A et al (2024) Competing endogenous RNAs regulatory crosstalk networks: the messages from the RNA world to signaling pathways directing cancer stem cell development. Heliyon 10(15):e35208","journal-title":"Heliyon"},{"issue":"7","key":"11463_CR16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.32604\/or.2023.030771","volume":"32","author":"X Huang","year":"2024","unstructured":"Huang X, Chen C, Chen Y, Zhou H, Chen Y, Huang Z et al (2024) Silencing of the long non-coding RNA LINC00265 triggers autophagy and apoptosis in lung cancer by reducing protein stability of SIN3A oncogene. Oncol Res 32(7):1185\u20131195","journal-title":"Oncol Res"},{"key":"11463_CR17","doi-asserted-by":"publisher","first-page":"907472","DOI":"10.3389\/fonc.2022.907472","volume":"12","author":"T Chen","year":"2022","unstructured":"Chen T, Liu J, Zhang H, Li J, Shang G (2022) Long intergenic noncoding RNA00265 enhances cell viability and metastasis via targeting miR-485-5p\/USP22 axis in osteosarcoma. Front Oncol 12:907472","journal-title":"Front Oncol"},{"issue":"6","key":"11463_CR18","first-page":"294","volume":"24","author":"B Ge","year":"2022","unstructured":"Ge B, Zhang X, Zhou W, Mo Y, Su ZH, Xu G et al (2022) LINC00265 promotes metastasis and progression of hepatocellular carcinoma by interacting with E2F1 at the promoter of CDK2. Cell J 24(6):294\u2013301","journal-title":"Cell J"},{"issue":"4","key":"11463_CR19","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s41418-019-0417-3","volume":"27","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Gu L, Lin X, Cui K, Liu C, Lu B et al (2020) LINC00265 promotes colorectal tumorigenesis via ZMIZ2 and USP7-mediated stabilization of \u03b2-catenin. Cell Death Differ 27(4):1316\u20131327","journal-title":"Cell Death Differ"},{"key":"11463_CR20","doi-asserted-by":"publisher","first-page":"102405","DOI":"10.1016\/j.genrep.2025.102405","volume":"42","author":"M Maghsudlu","year":"2026","unstructured":"Maghsudlu M, Razipour M, Ghadami E, Karimi E, Damavandi E, Saeedi N et al (2026) Disruption of LINC00265\/miR-101-3p axis using SiRNA suppresses growth and promotes apoptosis in laryngeal cancer cells. Gene Rep 42:102405","journal-title":"Gene Rep"},{"issue":"12suppl","key":"11463_CR21","doi-asserted-by":"publisher","first-page":"S434","DOI":"10.1177\/09603271211043479","volume":"40","author":"Y Zhi","year":"2021","unstructured":"Zhi Y, Sun F, Cai C, Li H, Wang K, Sun J et al (2021) LINC00265 promotes the viability, proliferation, and migration of bladder cancer cells via the miR-4677-3p\/FGF6 axis. Hum Exp Toxicol 40(12suppl):S434\u2013S46","journal-title":"Hum Exp Toxicol"},{"issue":"2","key":"11463_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1134\/S2079086424020038","volume":"14","author":"C Qian","year":"2024","unstructured":"Qian C, Xu J, Hu A, Zhang Y (2024) The role of LncRNA LINC00265 in regulating proliferation of lung cancer cells via TATA-Box binding protein associated factor 1. Biology Bull Reviews 14(2):160\u2013166","journal-title":"Biology Bull Reviews"},{"issue":"22","key":"11463_CR23","first-page":"7867","volume":"22","author":"L Ma","year":"2018","unstructured":"Ma L, Kuai WX, Sun XZ, Lu XC, Yuan YF (2018) Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway. Eur Rev Med Pharmacol Sci 22(22):7867\u20137876","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11463-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11463-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11463-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:28:50Z","timestamp":1769599730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11463-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11463"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11463-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent forms were obtained from all study participants. The study protocol was approved by the ethical committee of Tehran University of Medical Sciences (IR.SBMU.MSP.REC.1404.015).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participant"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}}],"article-number":"331"}}